What are Intermediate-acting insulin drugs?

Intermediate-acting insulin drugs are pharmacologic agents that share a common mechanism (typically targeting Insulin receptor). 8 are currently marketed, with 2 more in clinical development.

What are the marketed Intermediate-acting insulin drugs?

Marketed Intermediate-acting insulin drugs include insulin NPH, Neutral protamine hagedorn insulin, NPH insulin (insulin isophane), NPH twice-daily, Switching to NPH insulin, isophane human insulin.

Intermediate-acting insulin

8 marketed 2 in Phase 3

This page covers all Intermediate-acting insulin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.

Targets

Insulin receptor

Marketed (8)

insulin NPH · Novo Nordisk A/S · Diabetes
Insulin NPH is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
Neutral protamine hagedorn insulin · Eli Lilly and Company · Diabetes
NPH insulin is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
NPH insulin (insulin isophane) · Sanofi · Diabetes
NPH insulin binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
NPH twice-daily · Charles Drew University of Medicine and Science · Diabetes
NPH insulin is an intermediate-acting insulin that lowers blood glucose by facilitating cellular glucose uptake and promoting anabolic metabolism.
Switching to NPH insulin · Providence Health & Services · Diabetes
NPH insulin is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
isophane human insulin · Novo Nordisk A/S · Diabetes
Isophane human insulin is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
Humulin-N · Taipei Veterans General Hospital, Taiwan · Diabetes
Humulin-N is an intermediate-acting insulin that lowers blood glucose by facilitating cellular glucose uptake and promoting anabolic metabolism.
Novolin N · Wockhardt · Diabetes
Novolin N is an intermediate-acting insulin that binds to insulin receptors on cells to facilitate glucose uptake and utilization, lowering blood glucose levels.

Phase 3 pipeline (2)

NPH human insulin · Sanofi · Diabetes
NPH human insulin is an intermediate-acting insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
Insulin Rinsulin® NPH · Geropharm · Diabetes
Insulin NPH is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.